LAUSR

We would like to thank Dr Taif Mukhdomi and DR Mark C. Kendall at Rhode Island Hospital for their interest in our paper and for taking the time to express their concerns. In their letter to the editor, Dr Taif Mukhdomi and DR Mark C. Kendall note critical points that need to be clarified by the authors. First, although the trial registration states that opioid consumption is a secondary outcome measure; we did not report on opioid consumption in the results. Because of as mentioned in the methods, systemic oral analgesics were provided as acetaminophen 3 g/day for 72 h postoperatively for all patients in both groups. This article is protected by copyright. All rights reserved.